1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Genomics Analysis & Statistics, April 2015 (p2)

Genomics Analysis & Statistics, April 2015 (p2)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

31-60 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • April 2015
  • by Global Markets Direct

Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the ...

  • Industries : Pharmaceutical, Research and Development
  • Countries : United States
The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

  • $ 1 395
  • Industry report
  • June 2015
  • by BioInformant Worldwide, L.L.C.

Purpose of Report: The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Proteomics - 30 EASTERN ASIAN COMPANIES PROFILES

Proteomics - 30 EASTERN ASIAN COMPANIES PROFILES

  • $ 1 250
  • Industry report
  • May 2015
  • by Expernova

Find in this report 30 profiles of innovative companies that are part of the expertise on Proteomics, in Asia. Impressive advances in biochemistry, cell physiology and genomics have been made since the ...

  • Industries : Genomics
  • Countries : Asia
Proteomics - 30 NORTH AMERICAN COMPANIES PROFILES

Proteomics - 30 NORTH AMERICAN COMPANIES PROFILES

  • $ 1 250
  • Industry report
  • May 2015
  • by Expernova

Find in this report 30 profiles of innovative companies that are part of the expertise on Proteomics, in North America. Impressive advances in biochemistry, cell physiology and genomics have been made ...

  • Industries : Genomics
  • Countries : North America
Proteomics - 30 EUROPEAN COMPANIES PROFILES

Proteomics - 30 EUROPEAN COMPANIES PROFILES

  • $ 1 250
  • Industry report
  • May 2015
  • by Expernova

Find in this report 30 profiles of innovative companies that are part of the expertise on Proteomics in Europe. Impressive advances in biochemistry, cell physiology and genomics have been made since the ...

  • Industries : Genomics
  • Countries : Europe
Proteomics - 30 GLOBAL COMPANIES PROFILES

Proteomics - 30 GLOBAL COMPANIES PROFILES

  • $ 1 250
  • Industry report
  • May 2015
  • by Expernova

Find in this report 30 profiles of innovative companies that are part of the global expertise on Proteomics. Impressive advances in biochemistry, cell physiology and genomics have been made since the sequencing ...

  • Industries : Genomics
  • Countries : World, Europe
Viral DNA Polymerase Inhibitors -Pipeline Insights, 2015

Viral DNA Polymerase Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Viral DNA Polymerase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Viral DNA Polymerase Inhibitors. The main objective ...

  • Industries : Genomics
Viral RNA Polymerase Inhibitors -Pipeline Insights, 2015

Viral RNA Polymerase Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Viral RNA Polymerase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Viral RNA Polymerase Inhibitors. The main objective ...

  • Industries : Genomics
VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2015

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the VCAM-1 (vascula ...

  • Industries : Genomics
DNA Minor Groove Binders -Pipeline Insights, 2015

DNA Minor Groove Binders -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, DNA Minor Groove Binders- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA Minor Groove Binders. The main objective of this report ...

  • Industries : Office Supply and Stationery, Office Goods, Genomics
RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors -Pipeline Insights, 2015

RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the RNA-Dependent RNA Polymerase ...

  • Industries : Genomics
DNA Methyltransferase Inhibitors -Pipeline Insights, 2015

DNA Methyltransferase Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, DNA Methyltransferase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA Methyltransferase Inhibitors. The main objective ...

  • Industries : Genomics
DNA Primase Inhibitors -Pipeline Insights, 2015

DNA Primase Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, DNA Primase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA Primase Inhibitors. The main objective of this report to ...

  • Industries : Genomics
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s -Pipeline Insights, 2015

Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Nucleotide Analog Reverse ...

  • Industries : Drug and Medication
30S Ribosomal Subunit (30S RNA) Inhibitors -Pipeline Insights, 2015

30S Ribosomal Subunit (30S RNA) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, 30S Ribosomal Subunit (30S RNA) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the 30S Ribosomal Subunit (30S RNA) Inhibitors. ...

  • Industries : Genomics
DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2015

DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, DNA-Dependent RNA Polymerase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA-Dependent RNA Polymerase Inhibitors. The ...

  • Industries : Genomics
50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2015

50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, 50S Ribosomal Subunit (50S RNA) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the 50S Ribosomal Subunit (50S RNA) Inhibitors. ...

  • Industries : Genomics
DNA Polymerase Alpha Inhibitors -Pipeline Insights, 2015

DNA Polymerase Alpha Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, DNA Polymerase Alpha Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA Polymerase Alpha Inhibitors. The main objective ...

  • Industries : Genomics
DNA Polymerase Beta Inhibitors -Pipeline Insights, 2015

DNA Polymerase Beta Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, DNA Polymerase Beta Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA Polymerase Beta Inhibitors. The main objective of ...

  • Industries : Genomics
Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2015 Update

Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • May 2015
  • by Global Data

Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company which offers diagnostics products and services in the area of oncology. Its products include DNA-FISH Probes, CGH Microarrays and Next-Generation ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
STRATEC Molecular GmbH - Product Pipeline Analysis, 2015 Update

STRATEC Molecular GmbH - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • May 2015
  • by Global Data

Summary STRATEC Molecular GmbH (STRATEC Molecular) formerly known as Invitek Biotechnolgy & Biodesign Ltd is a biotechnology company that provides solutions for nucleic acid sample collection, stabilization, ...

  • Industries : Genomics
  • Countries : Germany
Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2015 Update

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Industry report
  • May 2015
  • by Global Data

Summary Exploit Technologies Pte Ltd (Exploit Technologies) is a technology transfer company. It provides technologies for license in various sectors industries such as Electronics, energy, Environment, ...

  • Industries : Diagnostics, Diagnostics, Pathology
  • Countries : Singapore
Caprion Inc. - Product Pipeline Analysis, 2015 Update

Caprion Inc. - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • April 2015
  • by Global Data

Summary Caprion is a pharmaceutical company that provides proteomics biomarker and target identification services. The company provides services for target discovery and clinical validation of biomarkers ...

  • Industries : Diagnostics, Diagnostics, Medical Facility, Pathology
  • Countries : United States, Canada
Celera Corporation - Product Pipeline Analysis, 2015 Update

Celera Corporation - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • April 2015
  • by Global Data

Summary Celera Corporation (Celera) a subsidiary of Quest Diagnostics Inc is a pharmaceutical company that develops, manufactures, and commercializes molecular diagnostic products. The company offers products ...

  • Industries : Pathology, Genomics
  • Countries : United States
Axela Inc. - Product Pipeline Analysis, 2015 Update

Axela Inc. - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • April 2015
  • by Global Data

Summary Axela Inc. (Axela) is a medical device company that develops products for protein detection, characterization and monitoring products. The company offers instruments, biomarker content and related ...

  • Industries : Diagnostics, Diagnostics, Genomics, General Medicine and Specialty Medicine, Pathology, In Vitro Diagnostic, In Vitro Diagnostic
  • Countries : Canada
Vital Signs - The Analyst%s Perspective - April 2015 Issue 

Vital Signs - The Analyst%s Perspective - April 2015 Issue 

  • $ 450
  • Industry report
  • May 2015
  • by Frost & Sullivan

Scope This issue of Vital Signs, released on May 12, 2015, discusses Roche's acquisition of CAPP Diagnostics, IBM's announcments of deals with Apple, Johnson & Johnson, and Medtronic, 2014 US prescription ...

  • Industries : Genomics, General Medicine and Specialty Medicine, Diagnostics, Diagnostics
Vital Signs - The Analyst%s Perspective - March 2015 Issue

Vital Signs - The Analyst%s Perspective - March 2015 Issue

  • $ 450
  • Industry report
  • April 2015
  • by Frost & Sullivan

This issue of Vital Signs, released on April 3, 2015, discusses next-generation sequencing bioinformatics partnerships, FDA approval of Novartis's ZARXIO, 23andMe's foray into drug development, and Johnson ...

  • Industries : Genomics
  • Countries : United States
Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
Genetic Immunity, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genetic Immunity, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2015
  • by Global Data

Summary Genetic Immunity, Inc (Genetic Immunity) is a biotechnology company. The company discovers, develops and commercializes immunotherapeutic biologics for the treatment of chronic viral infections, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.